Cargando…

Low STYK1 expression indicates poor prognosis in gastric cancer

BACKGROUND: The expression of serine threonine tyrosine kinase 1 (STYK1), a member of the receptor protein tyrosine kinase (RPTK) family, is abnormal in several cancers. However, the molecular mechanism of STYK1 regulation of gastric cancer (GC) progression is unknown. MATERIALS AND METHODS: We eval...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Jian, Wang, Hao, Fang, Xiao, Li, Na, Hu, Hailiang, Bian, Maohong, Yang, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289209/ https://www.ncbi.nlm.nih.gov/pubmed/30584361 http://dx.doi.org/10.2147/CMAR.S181910

Ejemplares similares

Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients
por: Chen, Luguang, et al.
Publicado: (2017)

Aberrant STYK1 expression in ovarian cancer tissues and cell lines
por: Jackson, Kesmic A, et al.
Publicado: (2009)

Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer
por: Chen, Peng, et al.
Publicado: (2014)

Expression and Bioinformatics Analysis of Key miRNAs in Stored Red Blood Cells
por: Jian, Fang, et al.
Publicado: (2022)

High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients
por: Shi, Haihong, et al.
Publicado: (2019)

Phosphorylated STYK1 restrains the inhibitory role of EGFR in autophagy initiation and EGFR-TKIs sensitivity
por: Zhou, Cefan, et al.
Publicado: (2022)

High expression of fibronectin 1 indicates poor prognosis in gastric cancer
por: Sun, Yang, et al.
Publicado: (2020)

Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial–mesenchymal transition
por: Fan, Yu, et al.
Publicado: (2016)

Circulating Methylated XAF1 DNA Indicates Poor Prognosis for Gastric Cancer
por: Ling, Zhi-Qiang, et al.
Publicado: (2013)

Low expression of CDK5RAP3 and DDRGK1 indicates a poor prognosis in patients with gastric cancer
por: Lin, Jian-Xian, et al.
Publicado: (2018)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

Retraction Note to: Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial–mesenchymal transition
por: Fan, Yu, et al.
Publicado: (2018)

High USP22 expression indicates poor prognosis in hepatocellular carcinoma
por: Tang, Bo, et al.
Publicado: (2015)

Low PARP-1 expression level is an indicator of poor prognosis in patients with stage II and III gastric cancer
por: Park, Song Ee, et al.
Publicado: (2022)

Stem cell-like circulating tumor cells indicate poor prognosis in gastric cancer
por: Yi-Wen, Wang, et al.
Publicado: (2022)

Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells
por: Zhou, Jianping, et al.
Publicado: (2017)

Low Expression of CLEC2B Indicates Poor Prognosis in Melanoma
por: Zhang, Yanqiu, et al.
Publicado: (2023)

RBM15 condensates modulate m(6)A modification of STYK1 to promote tumorigenesis
por: Jiang, Amin, et al.
Publicado: (2022)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Wu, Junlong, et al.
Publicado: (2017)

High Hepsin expression predicts poor prognosis in Gastric Cancer
por: Zhang, Mingming, et al.
Publicado: (2016)

High expression of VCAN is an independent predictor of poor prognosis in gastric cancer
por: Li, Wenfei, et al.
Publicado: (2020)

Low Expression of ZNF154 is Related to Poor Prognosis in Gastric Cancer
por: He, Jinsong, et al.
Publicado: (2022)

Low Expression of CDK5 and p27 Are Associated with Poor Prognosis in Patients with Gastric Cancer
por: Sun, Yu-Qin, et al.
Publicado: (2016)

UBR5 oncogene as an indicator of poor prognosis in gastric cancer
por: Ding, Fanghui, et al.
Publicado: (2020)

Low SOX12 Expression Is Correlated With Poor Prognosis in Patients With Gastric Cancer
por: Yang, Kan-kan, et al.
Publicado: (2020)

Positive expression of ZNF689 indicates poor prognosis of hepatocellular carcinoma
por: Yi, Peng Sheng, et al.
Publicado: (2018)

LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer
por: Ran, Tao, et al.
Publicado: (2021)

High expression of long non-coding RNA NEAT1 indicates poor prognosis of human cancer
por: Fang, Jian, et al.
Publicado: (2017)

LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis
por: Xie, Jian, et al.
Publicado: (2021)

Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer
por: Yang, Ziguo, et al.
Publicado: (2019)

Increased expression of protease-activated receptors 2 indicates poor prognosis in HBV related hepatocellular carcinoma
por: Chen, Peng, et al.
Publicado: (2019)

Decreased Expression of AZGP1 Is Associated with Poor Prognosis in Primary Gastric Cancer
por: Huang, Chun-yu, et al.
Publicado: (2013)

STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling
por: Lai, Yuanyang, et al.
Publicado: (2021)

STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer
por: Ma, Zhiqiang, et al.
Publicado: (2019)

Decreased expression of STING predicts poor prognosis in patients with gastric cancer
por: Song, Shushu, et al.
Publicado: (2017)

Reduced NKX2.1 Expression Predicts Poor Prognosis of Gastric Carcinoma
por: Zhao, Bai-Wei, et al.
Publicado: (2014)

Low PLCE1 levels are correlated with poor prognosis in hepatocellular carcinoma
por: Cheng, Ya, et al.
Publicado: (2016)

Low body mass index is an independent predictor of poor long-term prognosis among patients with resectable gastric cancer
por: Ma, Shuai, et al.
Publicado: (2021)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

Capn4 overexpression indicates poor prognosis of ovarian cancer patients
por: Yang, Ming-Fang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l2fbutvm8kbgimtgssgrs2o8c2